This event has concluded, but exciting conferences are happening worldwide — explore upcoming events in your field and stay ahead with the latest insights and networking opportunities. Subscribe to our newsletter.
3rd Tumor Myeloid-Directed Therapies Summit
103 103 people viewed this event.
The role of the myeloid compartment in tumor resistance is becoming clear. As the landscape of targets continues to grow, the potential to target and manipulate myeloid cells to relieve immunosuppression has received increasing focus, due to its ability to relieve immunosuppression in the tumor microenvironment.
Venue details: Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States
Prices: USD 2599.00 to USD 6046.00
Time: 09:00 to 17:00
Speakers: Andrea Casazza, Director – Biology, Montis Biosciences, Benjamin Umiker, Principal Scientist, Jounce Therapeutics, Chan Whiting, Chief Development Officer, Actym Therapeutics Inc., and more
Event Organizer - Hanson Wade